Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07313917) titled 'A Study to Evaluate the Efficacy and Safety of LP-003 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)' on Dec. 18, 2025.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Longbio Pharma
Condition:
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Intervention:
Biological: LP-003 Injection
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: January 20, 2026
Target Sample Si...